INTRODUCTION
Diabetes mellitus (DM) is a group of metabolic diseases characterized by increased blood glucose level resulting from defects in insulin secretion, insulin action, or both. 1 The incidence of diabetes is growing at dramatic rates around the world. 2 Diabetes mellitus (DM) is a major public health challenge in the century with over 190 million worldwide suffering from the disease now, and with a potential to have 324 million by 2025. The prevalence and incidence of type-2 diabetes varies among ethnic groups, such as higher rates in Asians than in western population even under the condition of similar body mass index. 3 Diabetes mellitus is a common endocrine disorders rising in India and has reached approximately 20% in urban populations and approximately 10% in rural populations. 4 DM is a metabolic pathology characterized by raised circulatory glucose, accompanied by diminished cellular glucose uptake and metabolism, as well as altered lipids and protein metabolism. 5 Hyperglycemia and atherosclerosis are related in type-2 diabetes. 6 Persistent hyperglycemia causes glycosylation of all proteins, especially collagen cross linking and matrix proteins of arterial wall. This eventually causes endothelial cell dysfunction, contributing further to atherosclerosis. The prevalence of dyslipidemia in diabetes mellitus is 95%. 7 The impact of coronary heart disease in industrialized countries as the leading cause of death in men and women is well documented 8, 9 and in the developing world it is now becoming an increasing cause of death. 10 Dyslipidemia occurs as a result of metabolic derangement which in type-2 diabetic patients is basically due to insulin resistance leading to defect in lipid handling. Insulin resistance, relative insulin defi ciency, .14mg/dl. The pattern of dyslipidemia in our study showed signifi cantly higher levels of serum cholesterol, serum triglyceride, LDL-C in both male and female diabetics and lower levels of HDL-C in female diabetics. There was no signifi cant difference in lipid profi le pattern in male and female diabetic patients except lower levels of HDL-C in female diabetic patients. Conclusion: This study showed that dyslipidemia is highly prevalent among type 2 diabetic patients.
Evaluation of dyslipidemia in type 2 diabetes mellitus
and obesity are associated with hypertriglyceridemia, low serum HDL cholesterol concentrations, and occasionally high serum low density lipoprotein (LDL) cholesterol and lipoprotein (a) values. 11, 12 Patients with diabetic dyslipidemia have lipid particles that are more atherogenic than in general population and even are at slightly increased risk of cardiovascular morbidity and mortality. 13 Insulin resistance, an important factor in type 2 diabetes mellitus, leads to excess liberation of free fatty acids from adipose tissue. 14, 15 The hepatic metabolism of lipoproteins to a large extent is controlled by insulin and this has implications for the lipid profi les and increases the risk of developing ischemic heart disease. 16 Treatment of dyslipidemia helps in prevention as well as control of other associated co-morbidities. The ability to diagnose and treat dyslipidemia in these patients may greatly enhance the quality of life. Hence the need to detect such cases where dyslipidemia contributes to morbidity and mortality and where it is the cause for poor control of the associated conditions. Therefore in present Study the prevalence of Dyslipidemia in Type 2 diabetes mellitus patients and the pattern of Dyslipidemia in type 2 diabetic patients is studied.
MATERIALS AND METHODS
The present cross sectional study entitled "Evaluation of dyslipidemia in type 2 diabetic patients" was carried out at department of medicine, L.N. Medical college and associated J.K. Hospital & Research Centre, Bhopal (M.P.) during 27/07/13 to 26/01/14. The study was carried out on 100 diabetic patients attending the medicine department during the study period. Informed consent was obtained from all the patients. 
Statistical analysis
After collection data were analyzed by using various required statistical methods like percentage, proportions and tables by using epi info software. Chi square test of signifi cant was used to see the statistical signifi cant of difference between males and females. P value of < 0.05 was considered signifi cant for the purpose of study.
OBSERVATION & RESULTS
The study population comprised of 100 patients of type 2 diabetics with a 72 males and 28 females, as shown in 17 The most important risk factor for these complications in diabetes is dyslipidemia. The present study was designed to evaluate the pattern of dyslipidemia in our study population.
The pattern of dyslipidemia in our study showed signifi cantly higher level of serum cholesterol, serum triglycerides, LDL-C and low level of HDL-C in female diabetic group. There was no signifi cant difference in lipid profi le pattern in male and female diabetic patients except lower levels of HDL-C in female diabetic patients. Data from the Paris Prospective Study 18 and the UKPDS shows that triglycerides in diabetic patients are higher than in the general population. 19 In our study triglycerides level were also signifi cantly higher in diabetics as compared to non-diabetic group. In our study serum cholesterol and LDL-C was found to be signifi cantly higher in type 2 diabetic patients which differs from earlier study which states that mean levels of total cholesterol and LDL-C in those with type 2 diabetes may not differ signifi cantly from those in non-diabetic subjects. 20 In our study in HDL-C levels have been found to be low in women than in men which is in concordance with earlier studies. 21 male patients and 42.32 mg/dl in female diabetic patients. Mean LDL-C level was 127.06 mg/dl in total patients, 127.30 mg/dl in male patients and 126.64 mg/dl in female diabetic patients as shown in table 3.
In type 2 diabetic patients mean triglycerides was found to be 152.02 mg/dl in total diabetic patients. Serum triglycerides < 150 mg/dl was found to be in total 60 (60%) diabetic patients, 44 (61.111%) male diabetics and 16 (57.142%) female diabetic patients. Serum triglycerides 150-399 mg/dl was found to be in total 40 (40%) diabetic patients, 28 (38.888%) male diabetics and 12 (42.857%) female diabetic patients as shown in table 4.
In type 2 diabetic patients mean serum LDL-C levels were found to be 127.06 mg/dl in total diabetic patients. Serum LDL-C < 100 mg/dl was found to be in total 18 (18%) diabetic patients, 12 (16.666%) male diabetics and 6 (21.428%) female diabetic patients. Serum LDL-C levels 100-129 mg/dl was found to be in total 31 (31%) diabetic patients, 22 (30.555%) male diabetics and 9 (32.148%) female diabetic patients. Serum LDL-C levels > 130 mg/dl was found to be in total 51 (51%) diabetic patients, 38 (52.777%) male diabetics and 13 (46.428%) female diabetic patients as shown in table 5.
In male type 2 diabetic patients serum HDL-C level > 35mg/dl was found to be in > 59 (81.944%) patients and HDL-C level < 35 mg/dl was found to be in 13 (18.055%) patients. In female diabetic patients serum HDL-C level > 45 mg/dl was found to be in 8 (28.571%) patients and HDL-C level < 45mg/dl in 20 (71.42) patients as shown in table 6 .
DISCUSSION
The present cross sectional study entitled "EVALUATION OF DYSLIPIDEMIA IN TYPE 2 DIABETIC PATIENT" was carried out at medicine department of L.N. Medical college and associated J.K. Hospital, Bhopal (M.P.). Type 2 diabetes accounts for more than 90% of all cases of 
CONCLUSION
Our present study concludes that there was signifi cantly higher levels of serum cholesterol, serum LDL-C level, serum triglyceride was found in type 2 diabetic patients, while serum HDL-C level was found to be signifi cantly low in female diabetics otherwise there was no signifi cant difference in lipid profi le pattern was found in between male and female diabetic patients.
In conclusion this study has shown that dyslipidemia is highly prevalent amongst type 2 diabetic patients. This combined dyslipidemia, put them to increased risk of cardiovascular, cerebrovascular and peripheral arterial diseases morbidity and mortality. Efforts should therefore be intensifi ed in the area of glycemic control, lipid lowering and lifestyle modifi cations among others to reduce the risk of morbidity and mortality in diabetic patients. Indeed the very high prevalence of dyslipidemia among diabetic subjects irrespective of duration of DM makes a case for early commencement of lipid lowering therapy even in the absence of biochemically proven dyslipidemia.
IMPLICATIONS
1. It will be helpful in understanding the prevalence and pattern of dyslipidemia in type 2 diabetes mellitus patients and also helpful in framing new policies and strategies to overcome it. 2. To initiate levels of prevention at the earliest possible stage and this is an important tool to prevent atherosclerosis and its consequences.
